Camden National Bank’s AstraZeneca AZN Stock Holding History

Camden National Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$293K	Buy	+1,544	New	+$290K	0.04%	149
2026 Q1	–	Sell	-1,216	Closed	-$223K	–	166
2025 Q4	$223K	Sell	1,216 -203	-14%	-$35.6K	0.03%	157
2025 Q3	$218K	Sell	1,419 -43	-3%	-$6.51K	0.03%	154
2025 Q2	$204K	Sell	1,462 -44	-3%	-$6.17K	0.03%	165
2025 Q1	$221K	Buy	+1,506	New	+$218K	0.03%	149

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Camden National Bank's AZN Position: Q2 2026 in Review

Camden National Bank opened a new position in AstraZeneca (AZN) in Q2 2026: 1,544 shares worth $293K. The stake represents 0.04% of the portfolio and ranks #149 among its holdings. This is a return to the name: Camden National Bank previously reported a position in AZN as recently as Q4 2025.

Camden National Bank first reported a position in AZN in Q1 2025 and has held it in 5 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Camden National Bank held 1,544 shares of AstraZeneca worth $293K as of Q2 2026.
AstraZeneca was a new Camden National Bank position in Q2 2026.
AstraZeneca made up 0.04% of Camden National Bank's portfolio in Q2 2026, its #149 holding.
Camden National Bank first reported a position in AstraZeneca in Q1 2025 and has held it in 5 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Camden National Bank's 13F filing for Q2 2026, filed 31 Jul 2026.